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Abstract
Implants trigger an inflammatory response, which is important for osseointegration. Here
we studied neutrophil extracellular trap (NET) release of human neutrophils in response to
sandblasted large-grit acid etched (SLA) implants using fluorescent, confocal laser scan-
ning and scanning electron microscopy. Our studies demonstrate that human neutrophils
rapidly adhered to SLA surfaces, which triggered histone citrullination and NET release.
Further studies showed that albumin or acetylsalicylic acid had no significant effects on the
inflammatory response to SLA surfaces. In contrast to bioinert materials, which do not
osseointegrate, the bioactivity of SLA surfaces is coupled with the ability to release NETs.
Further investigations are necessary for clarifying the role of NETosis for osseointegration.
Introduction
Endosteal implants are sterile foreign bodies surgically inserted into bone with an associated in-
flammatory host’s response [1–3]. In cases of bioinert implants, a soft tissue encapsulation
takes place. When bioactive implants are used, a direct interface forms between bone and im-
plants, i.e. osseointegration is achieved [1]. However, the intimate mechanisms of osseointegra-
tion and the differences between the initial responses to bioinert and bioactive implants remain
poorly defined.
In the initial stage of osseointegration, spaces around titanium implants are filled with
blood coagulum infiltrated with leukocytes [2,3] Polymorphonuclear neutrophils, (PMNs) are
rapidly recruited to sites of inflammation and have been shown to attach within minutes to ar-
tificial implant surfaces [4–6], triggering the production of reactive oxygen species (ROS) [7–
9]. Besides these findings, the fate and functionalities of human PMNs in response to implants
remained poorly understood. Upon infection and inflammation, PMNs expel their own DNA,
a process termed ‘neutrophil extracellular trap’ (NET) formation or ‘NETosis’, since the major
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form of NET formation is associated with PMN cell death [10]. NETs are efficient in limitation
of microbial spreading before sufficient quantities of leukocytes are recruited to the endangered
area [10]. However, NETs can also be triggered by non-infectious agents [10,11] or placental
microparticles [11] and can be harmful for the host [12–19]. Mechanistically, the production
of ROS [20] and the citrullination of histones [21,22] have been closely linked to NETosis. In
addition to PMNs, thrombocytes are also recruited to sites of inflammation and have been
shown previously to adhere to titanium surfaces [6,23,24]. Regarding PMN activation, platelets
have been described to drive NET formation through a mechanism involving Toll-like receptor
4 (TLR4) [16,17,25]. Based on these studies, we hypothesized that PMNs undergo NETosis in
response to implants.
For this purpose, we comprehensively studied (i) whether PMNs and thrombocytes attach
to SLA and poly-D-lysine-coated surfaces, (ii) whether NETosis occurs on such surfaces, and if
so, (iii) whether platelets, albumins, acetylsalicylic acid (ASA) and IgG contribute to implant-
induced NETosis. Therefore, we quantified the responses of PMNs and platelets after contact
with SLA surfaces of standardised titanium samples in a short-term incubation system. Our
studies demonstrate that PMNs form NETs in response to SLA implants. Understanding this
NET release by bioactive SLA implants might contribute to new possibilities for
modulating osseointegration.
Materials and Methods
Blood sampling and titanium plate preparation
Healthy, one month unmedicated volunteers without chronic diseases (n = 4, two male and
two female, aged between 25 and 39 years) were selected for donation of capillary blood. All
blood donors gave written consent to take part in the study. These studies were approved by
the ethical committee of the University of Tuebingen. Blood sampling from each volunteer was
performed in two sessions with an interval of at least one week. Capillary blood was collected
under sterile conditions from finger pricks using safety lancets and processed [26,27]. Samples
were directly transmitted from the fingertips of volunteers to the plates. In this way, the initial
stage of osseointegration was imitated as spaces around titanium implants are filled with blood
coagulum [1,2]. The direct blood sample transition also prevents the contamination with endo-
toxin [26,27]. The plates were produced from medical use titanium (ASTM F67 (DIN 3.7065),
containing 0.35% F, 0.1% C, 0.05% N, 0.35% O and 0.013% H) with the same sandblasted
large-grit acid etched (SLA) surface finish as used for SLA Octagon implants (Dental Ratio,
Düsseldorf, Germany). All plate surfaces were additionally UV sterilized for 1 hour prior to
further use. Blood attachment to the SLA surface was examined on three sets of differently pre-
treated plates: (i) uncoated, (ii) albumin-coated, and (iii) albumin/ASA coated. For coating,
plates were immersed in the respective solutions for 10 minutes (Table 1). To prepare surface
attachment samples, these plates were covered with fresh, untreated capillary blood immediate-
ly after coating and incubated in a humid chamber at 37°C and 5% CO2 for 4 hours. The same
procedure was applied to the set of uncoated (control) plates. Subsequently, the bulk of coagu-
lated blood was removed from the SLA surfaces with the help of fine tipped forceps, thus
Table 1. Surface treatment on SLA titanium plate sets.
Set Label surface type pre-treatment
1 C control (untreated SLA) none
2 ALB Albumin-coated SLA 5% human albumin in 0.9% NaCl
3 ASA albumin/ASA-coated SLA 5% human albumin and 1 mM acetylsalicylic acid in 0.9%NaCl
doi:10.1371/journal.pone.0121359.t001
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leaving only the directly surface-attached layer in place. The plates were then rinsed in phos-
phate buffered saline (PBS) and fixed in 4% paraformaldehyde in PBS. For immunocytochem-
istry-based quantification of PMNs and NETs, two samples on SLA plates were prepared per
subject, session and pre-treatment regime (Table 1), resulting in a total of 12 plates per pre-
treatment from 4 subjects. For the assessment of platelets by immunocytochemistry and SEM,
additional 4-hour-incubated samples on SLA plates, and also on uncoated or poly-D-lysine-
coated glass cover slips, were taken in at least one of the sessions (2–3 per subject in each case).
To test possible platelet disintegration early in the clotting process, further plates (again 2–3
per subject) were already fixed after 5 min of incubation.
Immunocytochemistry
For unambiguous identification of PMNs and for the detection of platelets, immunofluores-
cence staining was performed as follows: Samples were washed in phosphate buffered saline
(PBS, pH 7.4), blocked with 10% normal goat serum in PBS containing 10mM glycine and
0.2% Tween 20, and then incubated with primary antisera against appropriate molecular mark-
ers. Antisera against citrullinated histone H3 (mouse anti-human CitH3, cit R2+R8+R17 IgG1,
Abcam ab80256; 1:100) and neutrophil elastase (rabbit anti-human NE IgG, Abcam ab21595;
1:50) were employed for detection of PMNs, rat anti-human CD41 IgG1 (553847, BD Phar-
mingen, 1:100) for detection of platelets. Goat anti-rabbit DyLight 488 (Abcam ab96883;
1:100), goat anti-mouse TRITC (ab6786, Abcam, 1:100) and goat anti-rat Alexa Fluor 488
(A11006, Invitrogen, 1:1000) were applied as secondary antibodies. DNA was stained with
DAPI (Sigma Aldrich) or propidium iodide (P4170, Sigma Aldrich, Germany). Stained plates
were mounted on glass slides and coverslipped using GelMount (BioMeda) mounting medium,
and viewed and photographed in a Reichert Polyvar microscope equipped for fluorescence
microscopy.
Quantification of PMNs and NETs
For photo sampling, groups of 30 randomised non-overlapping photos per plate were taken
along two parallel transects across the entire surface, thus enabling adequate representation of
the central and peripheral areas. Image stacks of each group were created and analysed using
the software ImageJ. Cell numbers per stack were assessed using the cell counter plugin. PMNs
were identified by positive staining for NE, nucleated but NE-negative cells were classified as
‘other cells’. For the quantification of NETs, the outlines of areas covered by extracellular DNA
were traced and the total area per stack was measured in μm2. The software SPSS 20 was used
for data processing and statistical analysis. The three types of surface treatment (untreated, al-
bumin-coated, albumin/ASA-coated) were compared by univariate analysis of variance with
subject and sampling session as covariates, and by Tukey HSD post hoc test.
Confocal laser scanning microscopy (CLSM)
CLSM was employed to support qualitative screening for the presence of platelets. Samples on
poly-D-lysine-coated cover slips, either incubated for 4 h, or only for 5 min, and immuno-
stained for CD41 as described above, were analysed and photographed in a Zeiss LSM 510
meta UV CLSM (Carl Zeiss GmbH, Vienna, Austria).
Scanning electron microscopy (SEM)
SEM served to detect NETs and platelets. PFA-fixed samples on SLA plates and glass cover
slips were, dehydrated in a graded series of ethanols, critical point dried and sputter-coated
NETosis and Implants
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with gold, and finally viewed in a ESEM XL30 (FEI Company, Philips, Eindhoven, Nether-
lands) scanning electron microscope operating at 25 kV.
Results
Neutrophil adhesion
Examination of blood cell attachment to the surfaces of the SLA titanium plates under the fluo-
rescence microscope revealed that after 4 hours of incubation, several types of nucleated cells
had attached to the titanium surfaces of the plates of all three pre-treatment schedules (untreat-
ed, albumin-coated, albumin/ASA-coated) (Fig. 1A, S1 Fig., Table 1). The majority of the at-
tached cells (80.8% ± 5.4%–82.4% ± 5.1%) were PMNs as identified by immunolabelling for
NE (Fig. 1B-E, Fig. 2A, Fig. 3). Although there was no difference between pre-treatment sched-
ules in regard to the relative amounts of PMNs (Fig. 1E), total cell numbers were higher on the
surfaces of the uncoated control plates than on those of the two coated sets of plates (P< 0.05).
This suggested that a similar trend toward enhanced cell attachment to uncoated SLA surfaces
also exists for NE-negative cells. However, for these cells, a statistically significant difference
(P< 0.05, Fig. 1B,C) was only found between the uncoated and the albumin-coated plates
(Fig. 1B-E). SLA plates incubated for 5 min showed only a scarce presence of nucleated cells, a
finding contrasting to those incubated for 4 h. This difference strongly indicated that the PMN
transmigration from the bulk coagulum to the SLA surface is a lasting process and suggests
that the heterogeneity of NETotic stages of PMNs may be a consequence of their diverse time-
points of interacting with the SLA surface.
NETosis
A subset of PMNs attached to the SLA surface displayed diverse stages of NETosis as defined
by previous studies [20,28]. Accordingly, such cells stained positive for citrullinated histone
H3 (citH3) and showed swollen nuclei, a characteristic pattern of chromatin decondensation,
and—in some cases—also chromatin extrusion (Fig. 2A-D, Fig. 4). In addition to these NETo-
tic PMNs, the SLA surfaces were also decorated with fully spread NETs. These are in all rele-
vant morphological aspects similar to those of NETs from other in vitro and from in vivo
sources, as documented in previous studies on NETosis [10,29]. The areas covered by NETs
showed large variation between the individual samples and did not significantly differ between
the three pre-treatment regimes. All qualitative morphological findings on SLA surface at-
tached NETs made by fluorescence microscopy were supplemented by SEM analysis (Fig. 5D).
In contrast, no signs of NETs were observed on the poly-D-lysine-coated surface (Fig. 5B). We
did not observed any necrotic and any apoptotic PMNs.
Platelets
In order to test a possible interaction of platelet and PMN adhesion, the SLA surfaces of subsets
of plates from three pre-treatment regimes were screened for the presence of these characteris-
tic disc-shaped cell fragments. This was done by fluorescence microscopy after immunostain-
ing for CD41, and on separately prepared specimens under the SEM (see Methods). After four
hours of incubation, neither of these two methods succeeded in detecting the presence of plate-
lets (Table 2). Given this negative result, supplementary analyses by fluorescence microscopy,
SEM and CLSM were made using samples on SLA plates incubated for only 5 min, and samples
on uncoated and poly-D-lysine-coated glass cover slips incubated for 5 min or 4h. This was
performed in order to test whether the absence of platelets on the 4-hour-incubated plates was
due to quantitative disintegration during the incubation time, or rather due to (as yet
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undetermined) properties of the SLA titanium surface. SLA plates incubated for 5 min showed,
in contrast to those incubated for 4 h, a scarce but noticeable presence of platelets (Fig. 5B),
while more CD41 positive platelet aggregates could be found on poly-D-lysine-coated and un-
coated glass coverslips, particularly with those after 5 min incubation (Fig. 5A). The presence
of such platelet-aggregates on 4-hour-incubated uncoated cover slips was also confirmed by
SEM (Fig. 5C; Table 2).
Discussion
The inflammatory host response to bioactive implants is poorly understood, particularly the
role of PMNs. Here we demonstrate that human neutrophils rapidly adhered to SLA surfaces
and release extracellular DNA structures with characteristics of NETs. This finding also
Fig 1. Cell adhesion to SLA surfaces fromwhole peripheral blood with different pre-treatments. (A) Representative images of the three pre-treatment
groups (blue: DAPI, green: NE, red: CitH3), scale bar: 20μm. (B-F) Boxplots (interquartile range; line: median, whiskers: 1.5 x interquartile range) showing
absolute (B-D) and relative (E) cell numbers and the areas covered by NETs (F) for the three groups. Superscript letters indicate groups of statistically
significant differences. The three types of treatment were compared by univariate analysis of variance and by Tukey HSD post hoc test with subject and
sampling session as covariates,. Superscript letters (a, b) indicate groups of statistically significant differences at the P<0.05 level (similar letters: no
significant differences, different letters: significant difference).
doi:10.1371/journal.pone.0121359.g001
NETosis and Implants
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suggests that some NET components might be beneficial for osseointegration, supported by
the inability of bioinert materials to osseointegrate at all [1] and by the deterioration of osseoin-
tegration through administering anti-inflammatory drugs during the initial stages of osseointe-
gration [30–32].
Activated platelets can induce NETosis [16,17,25] and treatment with ASA, a platelet inhibi-
tor, has been described to decrease NET formation [16]. As a systematic pre-medication with
ASA is in general not feasible in dental implant surgery because of the risk of bleeding, we used
Fig 2. Characteristics of cells adhered to SLA surface from whole peripheral blood as detected by immunofluorescence. (A) NE-postitive PMNs with
their typically lobulated nuclei, and other NE-negative nucleated cells. (B) A single PMN committed to the NETotic cascade as clearly shown by
decompensated chromatin, the swollen, partly disrupted nucleus and NE and citH3 staining co-located with chromatin and at cytoplasmic locations. (C)
Chromatin extrusion from PMN. (D) Fully spread NETs between PMNs of different activation states. Scale bars: 10μm.
doi:10.1371/journal.pone.0121359.g002
NETosis and Implants
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the ASA ability to bind to albumin up to 85% [33,34] in order to apply it topically on the albu-
min-coated implant surface. This pattern of ASA application is surgically feasible, as the ASA
effects remain restricted closely to the implant surface. Despite the ability of thrombocytes
[6,23,24] to attach to titanium surface, the amount of SLA-adhered thrombocytes was not sig-
nificant und cells were completely lysed after four hours. The treatment with ASA did also not
affect the inflammatory response to the SLA surface. Thus, the lack of efficiency of the ASA
treatment strongly suggests that platelets are not involved in triggering NETosis on the SLA
surface in our experimental system.
Platelet lysis through ROS production has been previously reported [35,36] and the strong
respiratory burst on implants surfaces [7–9] as well as NETosis on SLA surface suggest that
ROS may be responsible for platelet lysis. Therefore, one may speculate that the NETosis/
thrombocyte relationship on SLA surface may differ from NETosis/thrombocyte relationships
within blood vessels, where NETosis and thrombocytes are closely associated and even activat-
ed thrombocytes have been described to induce NETosis [16,17,25].
Fig 3. Immunostaining of neutrophils. (A) 4h SLA sample. PMNs (white arrows) und others, not further determined, cells (black arrows). Blue—DNA
staining with DAPI, (B) red—immunostaining for CitH3, (C) immunostaining for neutrophil elastase, (D) merged. The other cells lack both NE and CitH3.
Scale bars: 50μm.
doi:10.1371/journal.pone.0121359.g003
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Our findings concerning the neutrophil adhesion are in accordance with earlier reports con-
cerning the neutrophil response to both smooth titanium [7–9] and other artificial implant sur-
faces [4–6]. However, PMNs adhered to SLA surface show diverse stages of NETosis,
characterized by swollen nuclei and chromatin alteration [20,22] as well as completely spread
NETs. In contrast, neither full NETs nor initial NETosis stages were evident on poly-D-lysine-
coated surfaces. Histone citrullination indicates PMNs activation and represents the initial
stage of NETosis on SLA [21,22]. In our studies, histone citrullination characteristics support
the notion that the vast majority of PMNs attached to SLA titanium surface undergoes NETo-
sis. A main trigger of the inflammatory response to smooth artificial surfaces is the adsorbed
IgG [9,37,38]. Pre-coating the artificial surfaces with albumin or fibrinogen disables the adhe-
sion of other proteins including IgG and essentially attenuates both PMN adhesion and inflam-
matory response on smooth artificial surfaces [37–40]. The pre-coating of smooth implant
surfaces with human IgG has resulted in considerable higher levels of cell activation [37–40].
In contrast, the albumin pre-coating of SLA surface in our experiments slightly attenuated
PMN adhesion, but had no significant effect on NETosis. These findings suggest that PMN
Fig 4. Immunostaining of neutrophils with NETs. 4h SLA sample. Staining as in Fig. 3. Overview: ripe NETs (arrows) between the adhered cells. Scale
bars: 50μm.
doi:10.1371/journal.pone.0121359.g004
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Fc-gamma-receptors may somewhat contribute to the adhesion to SLA surfaces, but do not in-
fluence the NETosis initiation on them. Consequently, another inflammatory stimulus,
Fig 5. Immunostaining of platelets (A) Detection of platelets adhered from whole peripheral blood to PDL-coated cover slips incubated for 5 min
by immunolabelling against CD41 (green). Large clusters of cells can be found accompanied by few individual nucleated cells (red—PI). Scale bar 10 μm.
(B) Platelets staining for CD41 (green) on SLA surface incubated for 5 min with whole peripheral blood are scarcely present between adhered PMNs as
shown by lobulated nuclei (blue—DAPI). Scale bar 20 μm. (C) Platelets shown by SEM on uncoated glass cover slips incubated for 4 h with whole peripheral
blood. Scale bar 5 μm. (D): SLA incubated for 4 h with whole peripheral blood show no platelets, but numerous erythrocytes as well as fine fibres with fibrin-
like and NET-like morphology. Scale bar 10 μm.
doi:10.1371/journal.pone.0121359.g005
NETosis and Implants
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considerable stronger than the non-self-recognition by IgG and/or complement, appears to
play the main role for the inflammatory response to the SLA surfacein our
experimental system.
SLA surfaces are micro/nano-textured TiO2-coated titanium surfaces, which accelerate the
osseointegration in comparison with the smooth titanium surfaces [41–43]. Indeed, the distinct
morphological characteristic of bioactivity of endosteal implants is their micro/nano-textured
surface [44,45]. Interestingly, micro- and nano-sized TiO2 particles have been demonstrated to
activate human PMNs [46] in vitro and to cause a pronounced inflammatory reaction in ani-
mal models marked by neutrophilia [47–49]. By virtue of the surface similarity, SLA surfaces
might comply similarly to micro- and nano-sized TiO2 particles. Indeed, both SLA surfaces
and nano-particles [50] are characterised by pronounced protein citrullination. The SLA sur-
face properties are a possible explication of the difference [51] between PMN inflammatory re-
sponses to smooth artificial surfaces [37–40] and SLA ones.
Collectively, our results demonstrate that the initial inflammatory response to bioactive im-
plants is marked by NETosis, which is not the case for bioinert poly-D-lysine-coated surfaces.
NETosis is the first reported mark of initial response to a bioactive implant, so far as the bioac-
tivity of endosteal implants has been defined only as the ability to osseointegrate. The deterio-
ration of osseointegration through administering anti-inflammatory drugs during the initial
stages of osseointegration [30–32] and the ability of statins to enhance both NETosis [52] and
osseointegration [53–55] also suggest that distinct components of the inflammatory response
to bioactive implants might be beneficial for the osseointegration. The in vivo role of NETosis
for osseointegration remains to be defined in future studies.
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Table 2. Presence of platelets on test surfaces as detected by different microscopic methods.
Surface detection method 5 min 4 h
SLA SEM ± -
FM ± -
glass coverslips glass coverslips Uncoated SEM no data +
poly-D-lysine CLSM ++ +
- not detectable
± scarcely present
+ present
++ abundantly present.
SEM: scanning electron microscopy; FM: ﬂuorescent microscopy, CLSM confocal laser scanning microscopy.
doi:10.1371/journal.pone.0121359.t002
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S1 Fig. SLA surface.Overview of the SLA micro/nano-textured surface. Scale bars: 5μm.
(TIF)
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